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BACKGROUND: Tuberculous meningitis (TBM) research remains important but 
obtaining adequate sample sizes of microbiologically-confirmed TBM cases is difficult, 
therefore clinical cases of TBM need to be included. A uniform research case definition 
for TBM was developed to assist diagnostic standardization. 
METHODS: Our study evaluated the proposed uniform research case definition in a 
group of children diagnosed with TBM. A subgroup of 66 children with culture-
confirmed TBM was compared to culture-confirmed bacterial meningitis controls. 
RESULTS: The uniform case definition was applied to 554 TBM patients. Sixty-six 
(11.9%) patients had definite TBM, 408 (73.6%) had probable TBM and 72 (13.0%) had 
possible TBM. Symptom duration >5 days, weight loss or persistent cough >2 weeks, 
recent TB contact, focal neurological deficit, clear cerebrospinal fluid (CSF) appearance 
and basal meningeal enhancement predicted TBM when compared to definite bacterial 
meningitis with a sensitivity and specificity of 97.0% and 93.7%, respectively. When 
using a probable TBM score as the diagnostic measure, sensitivity was 86% and 
specificity was 100%. When using a possible TBM score as the diagnostic measure, 
sensitivity was 100% but specificity was 56%. 
CONCLUSION: The uniform research case definition for TBM performed well when 
using a probable TBM score as the diagnostic marker. A regression model also 
differentiated TBM from bacterial meningitis with good accuracy, but caution is needed 
in its application to early TBM. 
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Staging: I 2(3) 5(1) 4(6) n/a 
               IIa 35(53) 214(52) 47(65) n/a 
               IIb 2(3) 16(4) 1(1) n/a 
               III 27(41) 172(42) 18(25) n/a 
Clinical criteria (Max category score=6) 
Symptom duration > 5 days 4 47(71) 366(90) 40(56) 6(19) 
>1 of: poor weight gain/weight loss, 
night sweats or persistent cough  >2 
weeks 
2 31(47) 204(50) 25(35) 1(3) 
History of recent TB contact or 
positive TST or IGRA  2 33(50) 291(71) 36(50) 2(6) 
Focal neurological deficit  1 33(50) 286(70) 27(38) 2(6) 
Cranial nerve palsy 1 18(27) 110(27) 17(24) 2(6) 
Altered consciousness 1 46(70) 398(98) 65(90) 19(59) 
CSF criteria (Max category score=4) 
Clear appearance 1 66(100) 408(100) 72(100) 18(56) 
Cells: 10–500 per µl 1 55(83) 361(88) 56(78) 20(63) 
Lymphocytic predominance (>50%) 1 51(77) 326(80) 53(74) 19(59) 
Protein concentration >1 g/L 1 49(74) 292(72) 42(58) 15(47) 
CSF to plasma glucose ratio <50% 1 47(71) 263(64) 34(47) 17(53) 
Cerebral imaging criteria (Max category score=6) 
Hydrocephalus 1 63(96) 353(87) 51(71) 9(28) 
Basal meningeal enhancement 2 48(73) 318(78) 19(26) 1(3) 
Tuberculoma 2 5(8) 55(13) 5(7) 1(3) 
Infarct 1 15(23) 142(35) 3(4) 3(9) 
Pre-contrast basal hyperdensity 2 No data No data No data 0(0) 
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Evidence of tuberculosis elsewhere (Max category score=4) 
Chest Xray suggestive of active TB 2 26(3) 206(50) 17(24) 3(9) 
Chest Xray suggestive of miliary TB 4 11(17) 53(13) 1(1) 0(0) 
CT/ MRI/ US evidence for TB 
outside CNS 2 0(0) 0(0) 0(0) 0(0) 
positive extraneural M.tb 
microscopy/culture 4 19(29) 100(25) 2(3) 0(0) 
Positive extraneural commercial 
NAAT  4 No data No data No data 0(0) 
Exclusion of alternative diagnoses 
An alternative diagnosis must be confirmed microbiologically, serologically or histopathologically 
Definite TBM = CSF: AFB on microscopy, positive M.tb culture, or a positive commercial NAAT 
Probable TBM = total score of ≥12 when neuroimaging available 
                         = total score of ≥10 when neuroimaging unavailable 
Possible TBM = total score of 6-11 when neuroimaging available 
                         = total score of 6-9 when neuroimaging unavailable 
 
TBM= tuberculous meningitis, BM= bacterial meningitis, TB= tuberculosis, 
TST=tuberculin skin test, IGRA=interferon gamma-release assay, CSF= cerebrospinal 
fluid, CT= computed tomography, MRI= magnetic resonance imaging, US= ultrasound, 
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Table 2. Findings on univariate analysis when comparing definite TBM to definite 
bacterial meningitis. Relative risk, 95% confidence interval and p values are shown. 
 
 OR (95% CI) p value 
Symptom duration > 5 days  10.7 (3.8-30.2) 0.000 
Weight loss or persistent cough > 2 weeks 27.5 (3.5-213.1) 0.002 
Recent close TB contact or pos TST/IGRA 15.0 (3.3-67.9) 0.000 
Focal neurological deficit 15.0 (3.3-67.9) 0.000 
Cranial Nerve Palsy  5.6 (1.2-26.0) 0.027 
Altered level of consciousness 1.6 (0.7-3.8) 0.312 
Clear CSF appearance 50.6 (6.2-410.7) 0.000 
CSF cells 10-500/µl 3.0 (1.1-7.9) 0.260 
Lymphocyte predominance >50% 1.6 (0.6-4.0) 0.366 
Raised protein >1g/L 3.3 (1.4-7.9) 0.009 
CSF:serum glucose ratio <50%  2.2 (0.9-5.2) 0.080 
Hydrocephalus 53.7 (13.4-215.7) 0.000 
Basal meningovascular enhancement 82.7 (10.5-651.0) 0.000 
Tuberculoma 2.5 (0.3-22.7) 0.404 
Infarct 2.8 (0.8-10.7) 0.121 
CXR suggesting active TB 6.3 (1.7-22.8) 0.005 
CXR suggesting military TB 6.2 (0.8-50.3) 0.088 
Positive extraneural M.tb microscopy 
and/or culture 
12.5 (1.6-98.5) 0.016 
 
OR= odds ratio, CI= confidence interval, TB= tuberculosis, TST=tuberculin skin test, 
IGRA=interferon gamma-release assay, CSF= cerebrospinal fluid, CXR= chest X-ray, 
AFB= acid-fast bacilli 
 
Stellenbosch University  http://scholar.sun.ac.za
9	  
	  
Table 3. Multivariable logistic regression analysis 
 
 OR 95% CI p-value 
Symptom duration >5 days 14.12 3.59 55.50 0.000 
Weight loss or persistent cough > 2weeks 55.07 5.71 530.92 0.001 
Recent close TB contact or pos TST/IGRA 18.99 3.22 111.95 0.001 
Constant 0.148   0.000 
  
OR=odds ratio, CI=confidence interval, TB= tuberculosis, TST=tuberculin skin test, 






















Tuberculosis (TB) remains a global health problem with a high morbidity and mortality, 
despite effective anti-tuberculous medication. Although the situation has improved in 
many areas, the absolute numbers are unchanged.1,2 TBM is the most devastating 
manifestation of TB, mostly due to delayed diagnosis from non-specific early symptoms 
such as cough, loss of weight, fever, vomiting and malaise. With disease progression, a 
more definitive clinical picture becomes manifest.3 Early initiation of treatment, and 
therefore early diagnosis of TBM, is the most critical factor affecting morbidity and 
mortality.4,5 
 
Culture of Mycobacterium tuberculosis (M.tuberculoisis) from cerebrospinal fluid (CSF) 
provides a definitive criterion for TBM diagnosis. TBM is paucibacillary, resulting in 
low sensitivity (10-20%) of CSF microscopy for acid-fast bacilli.6 Culture of CSF has a 
poor sensitivity of less than 50%3,7,8 and can take up to 42 days to provide a positive 
result. A meta-analysis of the accuracy of nucleic acid amplification tests (NAATs) for 
the diagnosis of TBM showed that commercial NAATs had a sensitivity of 56% and a 
specificity of 98%, and although providing a definite diagnosis, it is a poor ‘rule out’ 
test.9  
 
There are still many unanswered question regarding TBM treatment.10 A recent 
international health review found that existing trials assessing anti-tuberculous treatment 
for TBM had limited power, poor methodology and used varying treatment regimens 
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with conflicting results. Ideally, multi-centre randomized controlled trials are required, 
standard diagnostic and staging criteria should be applied and sufficient numbers should 
be recruited to demonstrate differences in outcome.11 As it is difficult to obtain adequate 
sample sizes using microbiologically confirmed TBM cases, probable and possible 
clinical cases of TBM need to be included. 
 
Recently, a uniform research case definition for TBM in adults and children was 
developed to achieve standardization of diagnosis for research purposes,12 but it would be 
useful if this definition could also be applied in clinical settings. The research tool 
defines TBM as definite if acid-fast bacilli are visualized and/or culture of 
M.tuberculosis from CSF is obtained and/or a commercial NAAT is positive. The clinical 
diagnosis of probable or possible TBM is based on clinical findings and special 
investigations. The boundaries between groups are not fixed, and patients can move 
between groups.  
 
Patients must have a clinical diagnosis of meningitis before the uniform research case 
definition can be applied. A scoring system then determines whether a patient falls in the 
probable or possible TBM category (Table 1). The scoring system was based on literature 
review of diagnostic algorithms for TBM in adults and/or children, expert experience and 
consensus decision.13-17 The threshold for inclusion should not be too high to exclude 
stage I TBM cases as this is the group with best outcome, but sometimes is the most 
difficult in which to make a diagnosis. 
 
Our study tests this uniform research case definition on a group of children diagnosed 
with, and treated for, TBM in a tertiary care hospital.  




Patients and methods 
 
The aim of this study was to test a recently proposed research case scoring system12 by 
application of the scoring systems to a clinical case series of 554 children under age 13 
years, fulfilling a case definition of TBM, that were prospectively collected between 
January 1985 and April 2005. Within this case series, a subgroup of 66 children with 
culture-confirmed (definite) TBM was identified, and compared to a control group with 
culture-confirmed (definite) bacterial meningitis. Thirty-two children, aged <13 years, 
and diagnosed between 2003 and 2009 were identified from the National Health 
Laboratory Service database. The study was conducted at Tygerberg Children’s Hospital, 
Cape Town, the tertiary academic hospital of the Faculty of Medicine & Health Sciences, 
Stellenbosch University. The study was approved by the Human Research Ethics 





Definition of definite TBM 
A diagnosis of definite TBM was made if acid-fast bacilli were identified on CSF 
microscopy and/or M.tuberculosis was cultured from CSF. 
 
Case definition of TBM 
A diagnosis of probable TBM was made when 2 or more of the following criteria were 
Stellenbosch University  http://scholar.sun.ac.za
13	  
	  
present in the setting of a characteristic history and CSF changes associated with TBM: a 
positive history of contact with an adult TB case, a positive tuberculin skin test, a chest 
x-ray suggestive of pulmonary tuberculosis (hilar lymphadenopathy, miliary tuberculosis 
or cavitation), computed tomography (CT) or  magnetic resonance imaging (MRI) 
demonstrating features of TBM (hydrocephalus, meningovascular enhancement and/or 
granuloma/s), poor weight gain and positive microbiological identification of acid-fast 
bacilli from gastric washings.3 
 
Definition of definite bacterial meningitis 
A diagnosis of definite bacterial meningitis was made if bacterial pathogens were 




Table 1 illustrates the diagnostic scoring criteria used. Points are allocated in the 
following categories: 1) clinical findings 2) CSF results 3) neuroimaging findings 4) 
evidence for TB outside the central nervous system and 5) additional laboratory criteria. 
A total score of at least 12 is compatible with probable TBM (when neuroimaging is 
unavailable, the total score is reduced to at least 10), while a total score of 9-11 equates 
to a possible TBM diagnosis (when neuroimaging is unavailable the total score required 
is reduced to 6-9). A certain number of points have to come from the CSF or neuro-
imaging criteria to ensure that the patient is indeed suffering from meningitis and not 
some other chronic type of tuberculosis. It was suggested by the consensus group that 
alternative causes for the clinical presentation must be excluded by means of the 
following CSF investigations:1) Gram stain and bacterial culture 2) India ink stain, 
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cryptococcal antigen latex agglutination test and cryptococcal culture 3) investigations to 
exclude neurosyphilis 4) cerebral malaria investigations in endemic areas 5) viral culture 
and polymerase chain reaction (PCR) if clinically indicated. Due to the retrospective 
nature of the study, the following diagnostic criteria could not be evaluated: pre-contrast 
basal hyperdensity on CT, CT/MRI/Ultrasound imaging of TB outside the CNS and 
positive polymerase chain reaction (PCR) evidence of extra-neural TB. 
 
The stage of TBM in each patient was also determined as follows: Stage I) Glasgow 
Coma Scale (GCS) of 15 and no focal neurology Stage IIa) GCS of 15 plus focal 




The Statistical Package for the Social Sciences version 19 (SPSS Inc, Chicago, IL, USA) 
and SAS (Statistical analysis system) version 9.1 (SAS Institute Inc., Cary, North 
Carolina, USA) was used for statistical analysis. Frequencies of the scoring criteria in the 
case-definition TBM and bacterial meningitis groups were obtained. We used the 
Fishers-exact test and odds ratios in univariate analyses to compare the definite TBM 
group and the definite bacterial meningitis control group. Two-tailed statistical 
significance was determined at p<0.05. To study the independent effect of variables, 
multivariate logistic regression analysis was used. Variables in the uniform research case 
definition were included, step-wise, in a multivariate logistic regression model, for which 
statistical significance was set at the 5% level. A receiver operating characteristic (ROC) 
curve was constructed. The area under the curve (AUC) was used to distinguish between 
patients with definite TBM and definite bacterial meningitis. An AUC of >0.70 is 
generally considered to be adequate for determining accuracy.  






To enter the TBM study group, children had to fulfill the probable case definition for 
TBM. All 554 patients fulfilled these criteria. The uniform case definition was then 
applied. According to the uniform research case definition criteria, 66 (11.9%) patients 
had definite TBM, 408 (73.6%) had probable TBM and 72 (13.0%) had possible TBM. 
Eight patients scored as unlikely TBM. Out of this last subgroup, 3 patients had no CSF 
or neuroimaging investigations, 2 had no CSF investigations, and the remaining three 
patients had poor clinical criteria scores. Table 1 shows the diagnostic criteria frequency 
for each of the above groups. Only 8 out of the 554 patients with TBM, were HIV-
infected. Two-hundred and five patients in this study were HIV-negative; in 341 patients, 
the HIV status was unknown. HIV prevalence was low during the earlier years of the 20-
year period that the patients were recruited. 
 
In the possible TBM group, 25% of patients were stage III, compared to 42% and 41% in 
the probable and definite TBM groups respectively. This shows that disease severity at 
onset (staging) is more severe in the probable/definite group compared to the possible 
group.  
 
When scoring the patients independent of culture confirmation i.e. either as probable 
TBM, possible TBM or no TBM, the definite TBM group of 66 included 57 scoring as 
probable TBM and 9 scoring as possible TBM. The definite bacterial meningitis group of 
32 included 18 scoring as no TBM, but 14 scoring as possible TBM. When using a 
probable TBM score as a positive diagnostic test marker, sensitivity was 86% and 
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specificity was 100%. When the denominator was lowered to a possible TBM score, 
sensitivity was 100% and specificity was 56%. 
 
 Table 2 summarizes the univariate analysis of criteria in the uniform research case 
definition, when comparing definite TBM to definite bacterial meningitis. Variables in 
the uniform research case definition were entered step-wise in a multivariable logistic 
regression analysis model. All variables with p <0.10 were inserted in the model. It was 
also decided to keep duration of illness>5days (p=0.115) and weight loss and/or 
persistent cough longer than 2 weeks (p=0.105) in the model (Table 3).  The overall 
specified group percentage is 95.9% with a cut off of 50%, meaning that 95.9% of 
inclusions were correctly predicted by the statistical model used. The AUC of the 
constructed ROC curve (Figure 1) was 0.990 (95% confidence interval: 0.957–0.982) and 
at the cut point at the furthest left hand corner of the ROC curve, the sensitivity was 




TBM often presents with non-specific symptoms in stage I of the disease. It is precisely 
this period where the diagnosis needs to be made, as morbidity and mortality increases 
exponentially with disease progression. Stage I TBM, left untreated can progress to stage 
II, or even stage III within a short time. Therefore the need for rapid diagnosis, in order 
to initiate treatment at the earliest opportunity.  
 
However, ‘gold standard’ diagnosis of TBM is difficult, even in resource-sufficient 
settings. Microscopic detection of acid-fast bacilli has low sensitivity and is difficult due 
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to the paucibacillary nature of TBM5. Culture of M.tuberculosis on CSF also has 
unimpressive sensitivity and is time-consuming8-10, in a disease where a few days can 
make a significant difference and M.tuberculosis PCR on CSF, even though it holds 
promise, has low sensitivity11. There is definitely still a need, therefore, for combination 
of clinical, laboratory and neuroimaging criteria for early identification of TBM suspects, 
and early treatment initiation. We obtained good sensitivity and specificity for our 
condensed version of the uniform research case definition for TBM, compared to 
available diagnostic methods. 
 
In previous studies comparing TBM and bacterial meningitis, five features were 
predictive of a diagnosis of TBM: age, length of history, headache, white blood cell 
count, clear CSF appearance, total CSF white cell count, low CSF neutrophil proportion, 
and elevated CSF protein. 13,16 Good sensitivities and specificities were obtained using 
both a composite clinical reference standard, and when applied to a microbiologically 
proven M.tb reference standard.14 Our study only used clear CSF appearance in common 
with previous studies when predicting TBM vs bacterial meningitis. 
 
The study was limited by absence of data regarding pre-contrast basal hyperdensity, 
suggestive CT, MRI or ultrasound imaging of TB outside the CNS and positive 
polymerase chain reaction (PCR) evidence of extra neural TB. Pre-contrast basal 
hyperdensity was described only in 2004 and was therefore not available.19 Univariate 
analysis showed that the majority of criteria were associated with a diagnosis of definite 
TBM. All of the scoring criteria have been shown to delineate TBM in different studies, 
therefore were included in the research algorithm13. A set of six criteria; symptom 
duration >5 days, weight loss or persistent cough >2 weeks, recent TB contact, focal 
neurological deficit, clear CSF appearance and basal meningeal enhancement were 
included in the multivariate logistic regression model and good sensitivity and specificity 
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was obtained when predicting TBM. 
 
The proposed uniform research case definition, even though untested, was an attempt to 
improve methodology, compare data and encourage collaboration. The criteria in the 
algorithm was based on literature review and expert opinion.12 Our study found that when 
using a probable TBM score as a diagnostic marker against a ‘gold standard diagnosis of 
TBM, a sensitivity of 86% and 100% was obtained. This compared well to the regression 
model, with a lower sensitivity but perfect specificity. However, when using a possible 
TBM score as the diagnostic marker, the specificity was wholly inadequate. Even though 
the group of possible TBM is a grey area, with a number of false positives, the 100% 
sensitivity is encouraging, as the aim is precisely to start all children with TBM on early 
anti-tuberculous therapy. Reviewing the points allocated to criteria and groups in the 
research case definition needs to be looked at in future studies, as well as testing the 
criteria with larger sample sizes. 
 
The uniform research TBM case definition needs to be tested robustly in future 
prospective studies including bacterial meningitis, viral meningitis and normal CSF 
control groups, and in both adult and pediatric populations. 
 
It is important to appreciate that the diagnostic research criteria were not designed for use 
in clinical practice. The normal examination findings in stage I TBM is a limitation of the 
diagnostic criteria. It would therefore be less likely to score as probable TBM at an 
earlier stage of disease. The uniform case definition holds promise, especially in 
resource-constrained settings with limited diagnostic availability, until better rapid 
diagnostic testing becomes available. Larger prospective studies where the uniform case 
definition is robustly tested need to be performed. 






The uniform research case definition for TBM performed well when using a probable 
TBM score as the diagnostic marker, but less well when including possible TBM scores. 
Rigorous data collection needs to be ensured in order that information is obtained in all 
criterion categories in the case definition. The set of 6 criteria predicted by the regression 
model also had good accuracy when differentiating TBM from bacterial meningitis, and 
could easily be applied in clinical practice, but care should be exercised in applying this 
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